Get the app
US › Healthcare

eXoZymes, Inc. (EXOZ)

US · Healthcare · Biotechnology

$6.19+0.49%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-2.9M
EPS
$-0.33

Key statistics

Market cap
$61.0M
Forward P/E
0.0
P/B
15.95
Book value
$0.39
EPS (TTM)
$-1.20
52-week high
$18.40
52-week low
$4.35
50-day MA
$6.10
200-day MA
$9.06

Shareholding

Insiders
64.99%
Institutions
1.34%

Largest institutional holders

FundStake
Davidson Kahn Capital Management, LLC0.27%
Vanguard Capital Management, LLC0.24%
Geode Capital Management, LLC0.24%
Vanguard Fiduciary Trust Co0.10%
BlackRock Inc0.07%
Tower Research Capital LLC0.01%
Morgan Stanley - Brokerage Accounts0.01%
Mercer Global Advisors Inc.0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for eXoZymes, Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.